DYN Dynegy Inc.

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Dynegy Inc. (DYN) on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Dynegy Inc. (NYSE: DYN) stockholders concerning the proposed acquisition of the company by Vistra Energy (NYSE: VST).

Our investigation concerns whether Dynegy’s board of directors failed to adequately shop the company and obtain the best possible value for its stockholders before entering into a definitive merger agreement with Vistra Energy. Under the terms of the agreement, Dynegy stockholders will receive 0.652 shares of Vistra Energy common stock for each share of Dynegy common stock they own. Oaktree Capital Management and Terawatt Holdings LP, who hold approximately 20% of Dynegy’s outstanding shares combined, have entered into support agreements and have agreed to vote their shares in favor of the merger.

If you own Dynegy shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of Dynegy Inc., please go to http://www.bespc.com/dynegy. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.

EN
31/10/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Dynegy Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 26, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 19, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 15, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Dyne Therapeutics Inc: 1 director

A director at Dyne Therapeutics Inc bought 100,000 shares at 9.110USD and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch